Genomind was excited to highlight the importance of the biotech industry to Pennsylvania today when Representative Brendan Boyle, who represents Pennsylvania’s 13th Congressional District, visited our CLIA certified laboratory in King of Prussia, PA. This facility is where we perform our genetic testing that can help guide clinicians as to which mental health treatments are likely to work as intended, have no effect or cause adverse effects.
Rep. Boyle was joined on the lab tour by Christopher Molineaux, the President and CEO of Pennsylvania Bio, which works to ensure Pennsylvania is the nation’s hub for the life sciences by creating a business and public policy environment which fosters life sciences growth and success.
Thank you to Rep. Boyle and Christopher Molineaux for paying us a visit today!
Also published on Medium.